Pharmacogenomics In Rheumatoid Arthritis
There have been significant advances in developing treatments for rheumatoid arthritis (RA) in recent years. The problem is that response to treatment is not universal. For example, one of the first-line biological treatments for RA is tumor necrosis factor inhibitors …